SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 24 filers reported holding SPRING BK PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $26,000 | -13.3% | 19,077 | -6.8% | 0.00% | – |
| Q2 2020 | $30,000 | +57.9% | 20,477 | -0.4% | 0.00% | – |
| Q1 2020 | $19,000 | -47.2% | 20,553 | -12.0% | 0.00% | – |
| Q4 2019 | $36,000 | -48.6% | 23,353 | +15.0% | 0.00% | – |
| Q3 2019 | $70,000 | -57.8% | 20,307 | -54.8% | 0.00% | – |
| Q2 2019 | $166,000 | -28.8% | 44,963 | +102.7% | 0.00% | – |
| Q1 2019 | $233,000 | -46.3% | 22,187 | -46.8% | 0.00% | – |
| Q4 2018 | $434,000 | -27.7% | 41,701 | -16.2% | 0.00% | – |
| Q3 2018 | $600,000 | +15.6% | 49,774 | +13.6% | 0.00% | – |
| Q2 2018 | $519,000 | +47.0% | 43,799 | +90.7% | 0.00% | – |
| Q1 2018 | $353,000 | +7.6% | 22,966 | -6.2% | 0.00% | – |
| Q4 2017 | $328,000 | -3.0% | 24,475 | +21.9% | 0.00% | – |
| Q3 2017 | $338,000 | +244.9% | 20,077 | +176.9% | 0.00% | – |
| Q2 2017 | $98,000 | -12.5% | 7,250 | -42.0% | 0.00% | – |
| Q1 2017 | $112,000 | +12.0% | 12,500 | 0.0% | 0.00% | – |
| Q4 2016 | $100,000 | – | 12,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 615,384 | $8,332,000 | 1.29% |
| RTW INVESTMENTS, LP | 250,000 | $3,385,000 | 0.71% |
| Monashee Investment Management LLC | 100,000 | $1,354,000 | 0.57% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 275,728 | $3,733,000 | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 175,000 | $2,370,000 | 0.40% |
| TIEDEMANN ADVISORS, LLC | 362,049 | $4,902,000 | 0.36% |
| Morse Asset Management, Inc | 63,700 | $862,000 | 0.28% |
| Private Capital Advisors, Inc. | 56,250 | $762,000 | 0.25% |
| Crestline Management, LP | 98,581 | $1,335,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 112,500 | $1,523,000 | 0.17% |